Tratamiento ambulatorio con inmunoglobulina anticoronavirus (Outpatient Treatment with Anti-Coronavirus Immunoglobulin, OTAC)

Un estudio de investigación que prueba un tratamiento contra el COVID-19 en fase de investigación conocido como concentrado de inmunoglobulinas de administración intravenosa hiperinmunitarias (hIVIG) anticoronaviral.

Outpatient Treatment With Anti-Coronavirus Immunoglobulin (OTAC)

A research study testing an experimental COVID-19 treatment called anti-coronavirus hyperimmune intravenous immunoglobulin (hIVIG).

Scientific Advances at the Vaccine Research Center

Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection

SARS-CoV-2 Assessment of Viral Evolution Publications

Seattle Children’s Researchers Discover that Nanobodies Could Pack the Biggest Punch Against COVID-19 Variants and Resurgence

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://pulse.seattlechildrens.org/seattle-childrens-researchers-discover-that-nanobodies-could-pack-the-biggest-punch-against-covid-19-variants-and-resurgence/
Research Institution
Seattle Children’s Research Institute
Short Title
Seattle Children’s Researchers Discover that Nanobodies Could Pack the Biggest Punch Against COVID-19 Variants and Resurgence
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

SKI Research Reveals New Insights into Immune Response to Viral Infections — Including COVID-19

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.mskcc.org/news/sloan-kettering-institute-research-reveals-new-insights-immune-response-viral-infections-including-covid-19
Research Institution
Sloan Kettering Institute
Short Title
SKI Research Reveals New Insights into Immune Response to Viral Infections
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

Cross-cutting Pandemic Preparedness Efforts

The ability of NIAID to prepare for and mount a rapid and effective research response to an emerging pathogen relies on knowledgeable staff, up-to-date facilities and flexible infrastructure, cutting-edge technology, and a robust, centralized coordination hub.

Pandemic Preparedness Translational and Clinical Research

Diagnostics

NIAID will leverage its expertise in infectious diseases, genomics, proteomics, bioinformatics, and access to clinical samples to develop rapid-response diagnostics for biological threats and emerging infectious diseases. In close collaboration with other NIH institutes and USG agencies, NIAID will support the development new and improved point-of-care and home-based tests as well as ultrahigh-throughput central reference laboratory testing that can accurately detect signatures of infectious pathogens that are of high public-health consequence.

Pandemic Preparedness Preclinical Research

Pathogen Biology, Pathogenesis, and Host Immunity

Developing products that can protect against pathogens of concern is an integrated process that requires basic and applied research. Fundamental knowledge of pathogen biology; structural properties; mechanisms of transmission, including identification of viral vectors; viral lifecycle; viral entry mechanisms and host receptors; tissue tropism; and host immune responses is critical to efforts informing the development of MCMs against new, emerging, or remerging pathogens.

Subscribe to